医学
癌症
腹膜
转移
肿瘤科
腹膜癌病
治疗方式
内科学
重症监护医学
外科
结直肠癌
作者
Fadi S. Dahdaleh,Kiran K. Turaga
标识
DOI:10.1016/j.soc.2018.02.006
摘要
Gastric cancer (GC) has a predilection to metastasize to the peritoneum, denoting a poor prognosis. Treatment strategies available for advanced GC have significantly evolved over time and can be categorized into systemic, regional, and surgical. Although systemic therapies have been the mainstay for the treatment of advanced GC, their ability in achieving long-term survival in patients with peritoneal involvement is modest at best. This article describes advances in combined modality treatment of peritoneal metastases, specifically with an emphasis on peritoneal-directed therapies.
科研通智能强力驱动
Strongly Powered by AbleSci AI